Delivery Order SPE2DB20D3103-SPE2DB24FM7P1

Award Date 2/21/24
Potential Completion Date 2/22/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $49,750.34 firm fixed-price delivery order is for the supply of RIZATRIPTAN 10 MG ODT UD 3S, a pharmaceutical product, with an ultimate completion date of April 20, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, SPE2DB22D1106|SPE2DB24FEZJ1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,967.40 Firm Fixed Price delivery order is for the supply of 4565020822 ! RIZATRIPTAN 10 MG ODT UD 18S, a pharmaceutical product. The contract has an ultimate completion date of June 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,867.38 firm fixed-price delivery order covers the supply of 4,563,750,623 units of Rizatriptan 10 mg tablets for an ultimate completion date of February 26, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,468.43 delivery order contract is for the supply of RIZATRIPTAN 5 MG ODT UD 3S, a prescription medication. The award is part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $12,930.71 for the supply of RIZATRIPTAN 10 MG TABLET UD 18S. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract is not designated with a set-aside and represents an open competition award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs)...
This federal contract award is for the delivery of rizatriptan 10 mg tablets to the Defense Logistics Agency (DLA). The $2,526.96 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on October 24, 2024, with an ultimate completion date of October 25, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,496.89 firm fixed-price delivery order is for the supply of 18 doses of the medication Rizatriptan 10mg. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $7,238.14, is for the delivery of 4564945122 RIZATRIPTAN 10 MG ODT UD 3S. It is a firm fixed-price contract with a completion date of June 20, 2024. Amerisourcebergen holds two larger indefinite delivery contracts (IDCs) with the...
This federal contract award is for the delivery of RIZATRIPTAN 10 MG ODT UD 3S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price type, valued at $95,673.52, and has an ultimate completion date of October 13, 2023. The...
This federal contract award, with ID SPE2DB22D1106|SPE2DB23FEHM1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,702.84 delivery order contract is for the supply of Rizatriptan 10 mg tablets to support defense healthcare programs. The contract is a firm fixed-price, non-set-aside award with a completion date of May 15, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FM7P1
    Delivery Order

This federal contract award, valued at $1,629.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of RIZATRIPTAN 5 MG ODT UD 18S, with a performance period ending on February 22, 2024.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:43 AM